SPAST and hereditary spastic paraplegia: So far, no clinical trials are active for HSP, but it has been demonstrated that GA reduces ER stress and improves locomotor and cellular defects in C. elegans, Drosophila, and zebrafish SPG4 animal models (Julien et al., 2016), suggesting that GA could be another promising drug for the treatment of HSP.